Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.2% | −5.3% | −3.2% | −3.3% | +15.2% | +17.3% | +41.2% | +10.7% | +132.8% | +571.8% |
| Peer average | −1.5% | −5.1% | −2.8% | −5.1% | +15.0% | +19.1% | +61.3% | +21.3% | +153.6% | — |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$27 of every $1,000 in FXH is Zimmer
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | ZBHZimmer Biomet | Healthcare | 2.71% | $270.92 | 301K | $31.1M |
| 2 | CNCCentene | Healthcare | 2.53% | $252.90 | 430K | $29.0M |
| 3 | UHSUniversal Health Services, () | Healthcare | 2.49% | $248.71 | 153K | $28.5M |
| 4 | CIThe Cigna Group | Healthcare | 2.45% | $244.52 | 98K | $28.1M |
| 5 | MEDPMedpace | Healthcare | 2.41% | $241.39 | 43K | $27.7M |
| 6 | GEHCGE HealthCare Technologies | Healthcare | 2.38% | $238.47 | 327K | $27.4M |
| 7 | REGNRegeneron Pharmaceuticals | Healthcare | 2.32% | $232.35 | 28K | $26.7M |
| 8 | SOLVSolventum | Healthcare | 2.29% | $228.51 | 303K | $26.2M |
| 9 | ZTSZoetis | Healthcare | 2.28% | $228.34 | 306K | $26.2M |
| 10 | DXCMDexCom | Healthcare | 2.23% | $222.74 | 310K | $25.6M |
| 11 | LLYEli Lilly and Company | Healthcare | 2.23% | $222.69 | 18K | $25.6M |
| 12 | GMEDGlobus Medical, () | Healthcare | 2.19% | $219.33 | 357K | $25.2M |
| 13 | EXELExelixis | Healthcare | 2.18% | $217.86 | 366K | $25.0M |
| 14 | MDTMedtronic | Healthcare | 2.08% | $208.32 | 237K | $23.9M |
| 15 | HALOHalozyme Therapeutics | Healthcare | 2.02% | $202.12 | 242K | $23.2M |
of the $110B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | ZBH | Zimmer Biomet | 2.71% |
| 2 | CNC | Centene | 2.53% |
| 3 | UHS | Universal Health Services, () | 2.49% |
| 4 | CI | The Cigna Group | 2.45% |
| 5 | MEDP | Medpace | 2.41% |
| 6 | GEHC | GE HealthCare Technologies | 2.38% |
| 7 | REGN | Regeneron Pharmaceuticals | 2.32% |
| 8 | SOLV | Solventum | 2.29% |
| 9 | ZTS | Zoetis | 2.28% |
| 10 | DXCM | DexCom | 2.23% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 24, 2026 | Sep 30, 2026 | $0.29 |
| Jun 25, 2026 | Jun 30, 2026 | $0.12 |
| Mar 26, 2026 | Mar 31, 2026 | $0.19 |
| Dec 12, 2025 | Dec 31, 2025 | $0.14 |
| Sep 25, 2025 | Sep 30, 2025 | $0.58 |
| Jun 26, 2025 | Jun 30, 2025 | $0.0616 |
| Mar 27, 2025 | Mar 31, 2025 | $0.0669 |
| Dec 13, 2024 | Dec 31, 2024 | $0.0899 |
| Sep 26, 2024 | Sep 30, 2024 | $0.13 |
| Jun 27, 2024 | Jun 28, 2024 | $0.11 |
| Mar 21, 2024 | Mar 28, 2024 | $0.11 |
| Dec 22, 2023 | Dec 29, 2023 | $0.13 |